Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 7
Author(s): Raymond G. Hill
Affiliation:
Export Options
About this article
Cite this article as:
Hill G. Raymond , Meet Our Editorial Board Member, Current Neuropharmacology 2017; 15 (7) . https://dx.doi.org/10.2174/1570159X1507170828105910
DOI https://dx.doi.org/10.2174/1570159X1507170828105910 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
A Closer Look to Polyesters: Properties, Synthesis, Characterization, and Particle Drug Delivery Applications
Nanoscience & Nanotechnology-Asia Pharmacological Advances in the Treatment of Insomnia
Current Pharmaceutical Design The Effect of Sodium Metabisulphite on Apoptosis in the Experimental Model of Parkinson’s Disease
Current Nutrition & Food Science Cardiac Nuclear Imaging: Current Status and Future Directions
Current Medical Imaging Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease
Current Alzheimer Research The Bcl-2 Family as a Rational Target for the Treatment of B-Cell Chronic Lymphocytic Leukaemia
Current Medicinal Chemistry Molecular Pathologies of and Enzyme Replacement Therapies for Lysosomal Diseases
CNS & Neurological Disorders - Drug Targets Cell Based-Gene Delivery Approaches for the Treatment of Spinal Cord Injury and Neurodegenerative Disorders
Current Stem Cell Research & Therapy Oxytocin Signaling Pathway: From Cell Biology to Clinical Implications
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Post-Translational Remodeling of Ryanodine Receptor: A New Track for Alzheimer's Disease Therapy?
Current Alzheimer Research New Synthons of 3-Hydroxyquinoline Derivatives Through S<sub>E</sub>Ar
Letters in Organic Chemistry Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats
Current Reviews in Clinical and Experimental Pharmacology Design, Synthesis and Biological Evaluation of Cyanopyridines, Pyridopyrazolopyrimidines and Pyridopyrazolotriazines as Potential Anticancer Agents
Current Organic Synthesis The SAMP8 Mouse: A Model to Develop Therapeutic Interventions for Alzheimers Disease
Current Pharmaceutical Design Editorial: Improving Neuropharmacology using Big Data, Machine Learning and Computational Algorithms
Current Neuropharmacology Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer’s and Parkinson’s Disease
Current Drug Metabolism Effects of Tetrahydroxystilbene Glucoside on Liver P450 Enzym e Expressions in Lipopolysaccharide-induced Dopamine Neuronal Dama ge Rats
Letters in Drug Design & Discovery Opioid-modulating Peptides: Mechanisms of Action
Current Topics in Medicinal Chemistry Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research